The discovery of new drug molecules depends on a number of steps, which limits the
development of feasible new drugs for the treatment of disease without any side effects …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have opened new
horizons in the pharmaceutical industry since they play a fundamental role in the field of …

Over the past decade, compared to all other macromolecules lipid-based nanocarriers have
proven to be an excellent carrier and delivery system for various pharmaceutical drugs of …

Drug delivery technology has a wide spectrum, which is continuously being upgraded at a
stupendous speed. Different fabricated nanoparticles and drugs possessing low solubility …

Nanotechnology has made a great impact on the pharmaceutical, biotechnology, food, and
cosmetics industries. More than 40% of the approved drugs are lipophilic and have poor …

The bioavailability of drugs is dependent on several factors such as solubility and the
administration route. A drug with poor aqueous solubility, therefore, poses challenges with …

The bioavailability of an orally administered drug primarily depends on its solubility in the
GIT and its permeability across cell membranes. Also, a drug in solution form is preferred for …

Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology
with several potential applications in drug delivery, clinical medicine and research, as well …

Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the
delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures …

Development of colloidal delivery systems has opened new avenues/frontiers for improving
drug delivery. Solid lipid nanoparticles have come up as the latest development in the arena …